Flavonoid Substituted Polysaccharides from Tamarix Chinensis Lour. Alleviate H1N1-induced Acute Lung Injury Via Inhibiting Complement System.
Yukun Jiao,Lishuang Zhou,Jiangyan Huo,Hong Li,Haiyan Zhu,Daofeng Chen,Yan Lu
DOI: https://doi.org/10.1016/j.jep.2023.117651
IF: 5.195
2024-01-01
Journal of Ethnopharmacology
Abstract:Ethnopharmacological relevance: Viral pneumonia is a highly pathogenic respiratory infectious disease associated with excessive activation of the complement system. Our previous studies found that the anticomplement polysaccharides from some medicinal plants could significantly alleviate H1N1-induced acute lung injury (H1N1-ALI). The leaves and twigs of Tamarix chinensis Lour. are traditionally used as a Chinese medicine Xiheliu for treating inflammatory disorders. Interestingly, its crude polysaccharides (MBAP90) showed potent anticomplement activity in vitro. Aim of the study: To evaluate the therapeutic effects and possible mechanism of MBAP90 on viral pneumonia and further isolate and characterize the key active substance of MBAP90. Materials and methods: The protective effects of MBAP90 were evaluated by survival tests and pharmacodynamic experiments on H1N1-ALI mice. Histopathological changes, viral load, inflammatory markers, and complement deposition in lungs were analyzed by H&E staining, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC), respectively. An anticomplement homogenous polysaccharide (MBAP-3) was obtained from MBAP90 by bio-guided separation, and its structure was further characterized by methylation analysis and NMR spectroscopy. Results: Oral administration of MBAP90 at a dose of 400 mg/kg significantly increased the survival rate of mice infected with the lethal H1N1 virus. In H1N1-induced ALI, mice treated with MBAP90 (200 and 400 mg/kg) could decrease the lung index, lung pathological injury, the levels of excessive proinflammatory cytokines (IL-6, TNF-alpha, MCP-1, IL-18, and IL-1 beta), and complement levels (C3c and C5b-9). In addition, MBAP-3 was characterized as a novel homogenous polysaccharide with potent in vitro anticomplement activity (CH50: 0.126 +/- 0.002 mg/ mL), containing 10.51% uronic acids and 9.67% flavonoids, which were similar to the composition of MBAP90. The backbone of MBAP-3 consisted of -> 4)-alpha-D-Glcp-(1 ->, -> 3,4,6)-alpha-D-Glcp-(1 ->, and -> 3,4)-alpha-D-Glcp-(1 ->, with branches comprising alpha-L-Araf-(1 ->, alpha-D-GlcpA-(1 ->, -> 4,6)-alpha-D-Manp-(1 -> and -> 4)-beta-D-Galp-(1 -> . Particularly, O-6 of -> 4)-beta-D-Galp-(1 -> was conjugated with a flavonoid, myricetin. Conclusions: MBAP90 could ameliorate H1N1-ALI by inhibiting inflammation and over-activation of the complement system. These polysaccharides (MBAP90 and MBAP-3) with relative high contents of uronic acid and flavonoid substituent might be vital components of T. chinensis for treating viral pneumonia.